India


India-EU FTA: What the deal means for digital trade and intellectual property rights
The deal points to creating a secure digital trade environment by promoting paperless transactions and cyber-security .
India-EU FTA: Both sides to adopt ‘most favoured nation tag’ for 5 years – What does this mean?
The two sides plan to grant each other MFN status for five years once the FTA goes into effect.
India, EU release provisional text of FTA with 20 chapters
No exemption from CBAM for India, separate chapter on model mediation procedures, services, review after five years.
The EU’s smaller-is-better moment
With mega trade agreements proving painfully slow, Brussels is warming to mini-deals.
Modi-Carney meet on Monday to see launch of free trade agreement talks
India and Canada will start talks on a free trade deal to double trade to $50 billion by 2030. They also advanced a 10-year uranium supply deal and agreed to cooperate in energy, critical minerals, AI, and defence, strengthening their strategic partnership.
India, Israel launch first round of FTA talks
India and Israel began the first round of negotiations for a proposed Free Trade Agreement in the national capital, with discussions scheduled from February 23 to 26, 2026.
Farmers mobilize nationwide against India-US trade pact
The Samyukta Kisan Morcha (SKM) announced a nationwide protest on Tuesday against the proposed India-US trade agreement and various policies.
India, Gulf Cooperation Council launch FTA talks
The negotiations for the proposed free trade agreement between India and the Gulf Cooperation Council were formally launched here with the signing of a joint statement.
Israel may sign free trade deal with India this year, says Israeli envoy
Israel and India are moving toward a Free Trade Agreement, potentially finalised this year. PM Modi's upcoming visit will also deepen defence ties and expand collaboration in technology, infrastructure, and innovation.
The promise of EU-India FTA for Indian patients: A case for price regulation
The EU-India FTA promises cheaper drugs and medical devices, but India's regulatory framework may hinder patient benefits. Current pricing mechanisms, including market-based ceiling prices and loopholes for fixed-dose combinations, prevent cost reductions from reflecting in retail prices. An urgent overhaul of drug pricing and an independent regulator for procedures are needed to ensure affordability and realize the FTA's full potential.